US EditionUS FDA grants de novo clearance for Reflow Medical’s Spur peripheral retrievable stent system - Interventional News
Summary by Interventional News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
US FDA grants de novo clearance for Reflow Medical’s Spur peripheral retrievable stent system - Interventional News
Reflow Medical recently announced that the US Food and Drug Administration (FDA) has granted de novo clearance for the company’s Spur peripheral retrievable stent system, which is designed for the treatment of de novo or restenotic lesions following predilatation in patients with infrapopliteal arterial disease. According to Reflow Medical, the Spur stent system is the first and only retrievable stent system that features a self-expanding stent …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
